CD40LG and COVID-19: Whether mild and severe COVID-19 represent 2 interlinked stages on a severity continuum or 2 distinct phenotypes of an infectious process (5) remains incompletely understood; detailed cross-sectional characterization of IgM and IgG reactive against SARS-CoV-2 antigens may provide insight into the temporal evolution of antibodies.